Insider Trading & Ownership - Lunger John

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lunger John
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-16
Sale
2024-01-17
5:30 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
22,795$0.69703$15,88919,015
(Direct)
View
2024-01-11
Sale
2024-01-12
5:00 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
9,229$0.84654$7,8137,874
(Direct)
View
2023-08-01
Sale
2023-08-01
5:00 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
3,096$0.9056$2,8044,718
(Direct)
View
2023-01-17
Sale
2023-01-17
9:17 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,440$1.858$8,2507,264
(Direct)
View
2023-01-11
Sale
2023-01-12
9:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
8,816$1.7238$15,1978,121
(Direct)
View
2023-01-04
Sale
2023-01-04
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,100$1.694$1,8631,725
(Direct)
View
2022-08-01
Sale
2022-08-01
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
2,983$1.7735$5,2904,829
(Direct)
View
2022-07-05
Sale
2022-07-05
9:00 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,973$1.6781$3,3113,104
(Direct)
View
2022-01-18
Sale
2022-01-18
9:03 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,368$3.1918$13,9427,336
(Direct)
View
2022-01-11
Sale
2022-01-13
9:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,846$3.5539$17,2221,749
(Direct)
View
2022-01-04
Sale
2022-01-05
9:06 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,070$4.0642$4,3491,755
(Direct)
View
2021-08-02
Sale
2021-08-02
5:09 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
2,939$3.5848$10,5364,873
(Direct)
View
2021-07-02
Sale
2021-07-02
8:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,907$4.2649$8,1333,170
(Direct)
View
2021-01-19
Sale
2021-01-19
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,358$5.6695$24,7087,346
(Direct)
View
2021-01-12
Sale
2021-01-12
9:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,058$6.1522$6,5091,767
(Direct)
View
2021-01-04
Sale
2021-01-05
9:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,065$5.3279$5,6741,760
(Direct)
View
2020-08-03
Sale
2020-08-04
9:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
4,823$9.25$44,6138,066
(Direct)
View
2020-01-14
Sale
2020-01-15
8:02 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,144$5.1347$5,8741,681
(Direct)
View
2020-01-06
Sale
2020-01-07
8:01 pm
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,148$1.2$1,3781,677
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-15
Option Award
2024-01-17
5:02 pm
N/A
2034-01-15
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
3,109,848$03,109,848
(Direct)
View
2023-01-17
Option Award
2023-01-17
9:06 pm
N/A
2033-01-17
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,912,248$01,912,248
(Direct)
View
2022-03-03
Option Award
2022-03-07
6:14 pm
N/A
2032-03-03
GENOCEA BIOSCIENCES INC.GNCALunger John
Director
30,000$030,000
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:04 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,721,328$01,721,328
(Direct)
View
2021-01-11
Option Award
2021-01-11
9:00 pm
N/A
2031-01-11
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,329,528$01,329,528
(Direct)
View
2020-01-16
Option Award
2020-01-17
9:33 pm
N/A
2030-01-16
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,538,640$01,538,640
(Direct)
View